Literature DB >> 17201725

Nonlesional frontal lobe epilepsy (FLE) of childhood: clinical presentation, response to treatment and comorbidity.

Julie Prévost1, Anne Lortie, Dang Nguyen, Maryse Lassonde, Lionel Carmant.   

Abstract

RATIONALE: Few studies have looked at long-term epileptic and cognitive outcome of frontal lobe epilepsy (FLE) in children. Most are limited by inclusion of lesional and nonlesional patients. GOAL: To define the epileptic and functional outcome of children with nonlesional FLE.
METHODS: We reviewed medical records and neuropsychological evaluations of patients with nonlesional FLE diagnosed between 1994 and 2004. We included children with either focal or regional frontal EEG and/or functional imaging abnormalities. We reviewed their charts for seizure and neuropsychological outcome.
RESULTS: We included 21 children. Twelve (57.1%) presented with daily seizures. Seizures were nocturnal in 8 of 21, secondarily generalized in 6 of 21, adversive in 5 of 21, and focal motor in 6 of 21. Although, initial seizure control was poor in 14 of 21, long-term control was achieved in 10 of 21 after 14.6+/-22.3 months. Early development was normal in 12 of 21 but at later formal neuropsychological evaluation only 3 of 12 still had a normal profile. The majority of children had learning difficulties requiring special education prior to seizure onset (6 of 10). A clearly defined regression after seizure onset was observed in three children. The majority exhibited attention deficit and hyperactivity or impulsivity (14 of 21), behavioral problems (8 of 21), and cognitive impairments (10 of 21). Early seizure control was associated with a better cognitive outcome.
CONCLUSION: Nonlesional FLE is associated with poor seizure and behavioral outcomes. Whether this is secondary to MRI-silent developmental lesions or to the progressive repercussion of seizures on frontal lobe functions remains uncertain. A prospective study with early neuropsychological assessment could help confirm the latter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201725     DOI: 10.1111/j.1528-1167.2006.00714.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Nocturnal frontal lobe epilepsy: there is bad, good, and very good news!

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2007 Sep-Oct       Impact factor: 7.500

Review 2.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

3.  Spectrum of attention deficit hyperactivity disorders (ADHD) among Sudanese children with epilepsy.

Authors:  Elwaleed E Ahmed; Inaam N Mohamed
Journal:  Sudan J Paediatr       Date:  2015

4.  Abnormal functional network connectivity among resting-state networks in children with frontal lobe epilepsy.

Authors:  E Widjaja; M Zamyadi; C Raybaud; O C Snead; M L Smith
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

Review 5.  The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity.

Authors:  Alberto Verrotti; Romina Moavero; Gianvito Panzarino; Claudia Di Paolantonio; Renata Rizzo; Paolo Curatolo
Journal:  Clin Drug Investig       Date:  2018-01       Impact factor: 2.859

Review 6.  Cognitive progression in epilepsy.

Authors:  Michael Seidenberg; Dalin T Pulsipher; Bruce Hermann
Journal:  Neuropsychol Rev       Date:  2007-11-08       Impact factor: 6.940

7.  Treating children with attention-deficit/hyperactivity disorder and comorbid epilepsy.

Authors:  Shivanand Kattimani; S Mahadevan
Journal:  Ann Indian Acad Neurol       Date:  2011-01       Impact factor: 1.383

8.  Memory functioning in children with epilepsy: frontal lobe epilepsy, childhood absence epilepsy, and benign epilepsy with centrotemporal spikes.

Authors:  Ana Filipa Lopes; José Paulo Monteiro; Maria José Fonseca; Conceição Robalo; Mário Rodrigues Simões
Journal:  Behav Neurol       Date:  2014-08-03       Impact factor: 3.342

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.